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	 The	 crystal	 of	 the	 title	 compound,	 C21H36O3	 contains	 an	 oxolane	 ring,	 and	 six	 defined
stereocenters	 which	 are	 unambigously	 established	 by	 the	 crystallography	 study.	 A	 three
dimensional	 supramolecular	 architecture	 is	 ensured	by	hydrogen	bonds	 from	 the	hydroxy
group	 which	 is	 both	 engaged	 in	 inter	 (O‐H···O2)	 and	 intramolecular	 C‐H···O‐H)	 hydrogen
bonds.	 Weak	 C‐H···O=C	 hydrogen	 bonds	 are	 involved	 also	 into	 the	 consolidation	 of	 the
network.	
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1.	Introduction	
	
Our	 constant	 interest	 in	 the	 chemistry	 of	 heterocyclic	
compounds	 and	 particularly	 in	 the	 synthesis	 of	 vitamin	 D	
analogues,	 has	 led	 us	 to	 develop	 several	 methods	 for	 the	
synthesis	of	these	compounds	[1,2].	We	also	considered	their	
biological	 activities	 which	 are	 studied	 in	 the	 literature	 [3].	
Recently,	 we	 reported	 the	 synthesis	 of	 a	 new	 vitamin	 D2	
analogue	and	the	evaluation	of	 its	biological	activity	on	colon	
cancer	[4].	In	the	continuation	of	our	work	on	the	analogues	of	
vitamin	 D,	 we	 synthesized	 two	 new	 molecules	 of	 calcitriol	
from	an	oxolane	ring	and	its	side	chains	[5].	In	this	study,	we	
present	 the	 structure	 of	 a	 new	 analog	 of	 calcitriol	 with	 six	
stereo	 centers.	 The	 crystal	 structure	 allowed	 elucidating	 the	
absolute	configuration	of	the	stereo	centers.	
	
2.	Experimental	
	
2.1.	Materials	and	physical	methods	
	
Diol	 and	 pyridinium	 dichromate	 (PDC)	 were	 purchased	
from	 Aldrich	 and	 used	 without	 further	 purification.	 The	 IR	
spectrum	 was	 recorded	 as	 KBr	 discs	 on	 a	 Bruker	 IFS‐66	 V	
spectrophotometer	 (4000‐400	 cm‐1).	 Mass	 spectrometry	was	
carried	out	with	a	Hewlett	Packard	5988A	spectrometer.	The	
1H	and	13C	NMR	spectra	of	the	compound	1	were	recorded	in	
CDCl3	on	a	BRUKER	500	MHz	spectrometer	at	room	tempera‐
ture	using	TMS	as	internal	reference.		
	
2.2.	Crystal	structure	determination	
	
Crystallographic	data	were	collected	at	room	temperature	
using	a	Bruker	Smart	6000	CCD	detector	and	Cu‐Kα		radiation		
(	=		1.54178		Å)		generated		by		a		Incoatec		microfocus		sour‐
ce		 equipped		with	 Incoatec		 Quazar	MX	 optics.	 The	 software	
APEX3	 [6]	 was	 used	 for	 collecting	 frames	 of	 data,	 indexing	
reflections	and	the	determination	of	lattice	parameters,	SAINT	
[6]	 for	 integration	of	 intensity	of	 reflections,	 and	SADABS	 [6]	
for	scaling	and	empirical	absorption	correction.	The	structure	
was	solved	by	dual‐space	methods	using	the	program	SHELXT	
[7].		
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Scheme	1
	
	
	
Figure	1.	Crystal	structure	of	the	compound	1.	
	
	
All	 non‐hydrogen	 atoms	 were	 refined	 with	 anisotropic	
thermal	 parameters	 by	 full‐matrix	 least‐squares	 calculations	
on	F2	using	the	program	SHELXL	 [8].	 Hydrogen	 atoms	 were	
inserted	at	calculated	positions	and	constrained	with	isotropic	
thermal	 parameters	 except	 for	 the	 hydrogen	 atom	 of	 the	
hydroxyl	group.	Drawings	were	produced	with	PLATON	[9].	
	
2.3.	Synthesis	of	compound	1	
	
To	 a	 solution	 of	 diol	 (2)	 (0.18	 mmol)	 in	 CH2Cl2	 (5	 mL),	
pyridinium	dichromate	(PDC)	(0.37	mmol)	was	added	and	the	
mixture	stirred	at	room	temperature	for	12	h,	then	the	solvent	
was	 evaporated	 and	 the	 residue	 was	 chromatographed	 on	
sılica	gel	using	 (10%,	EtOAc:hexane,	v:v)	 to	 afford	ketone	 (1)	
(Scheme	 1).	 The	 title	 compound	 was	 recrystallized	 using	 a	
mixture	of	hexane:ethyl	ether	(1:1,	v:v).		
(1R,	 3aR,	 7aR)‐1‐((S)‐1‐((2R,	 5S)‐5‐(3‐hydroxypentan‐3‐
yl)tetrahydrofuran‐2‐yl)ethyl)‐7a‐methyloctahydro‐4H‐inden‐
4‐one	 (1):	 Color:	 White	 solid.	 M.p:	 80‐82	 °C.	 Yield:	 88%.	 Rf:	
0.42	(30%,	EtOAc:hexane,	v:v).	[α]D19	=	+26.27	(c	1.0,	CDCl3).	1H	
NMR	(250	MHz,	CDCl3,	δ,	ppm):	3.99	(1H,	td,	J	=	10.1,	5	Hz,	H‐
5'),	3.81	(1H,	dd,	J	=	9.8,	5.7	Hz,	H‐2'),	2.42	(1H,	dd,	J	=	11.2,	7.4	
Hz,	H‐3a),	2.37‐1.70	(12H,	m,	6	x	CH2)	 ,	1.69‐1.24	(9H,	m,	3	x	
CH2	+	H‐1	+	H‐1'	+	HO),	0.93	(3H,	d,	J	=	6.7	Hz,	CH3‐21),	0.87	
(6H,	td,	J	=	7.5,	5.3	Hz,	CH3‐Et	),	0.66	(3H,	s,	CH3‐18).	13C	NMR	
(62.5	MHz,	CDCl3,	δ,	ppm):	211.91	(C=O),	83.49	(CH‐2'),	81.78	
(CH‐5'),	 74.76	 (C‐3''),	 61.43	 (CH‐14),	 54.23	 (CH‐17),	 50.30	
(CH‐13),	41.02	(CH2),	38.94	(CH2),	38.93	(CH‐20),	28.79	(CH2),	
26.91	 (CH2),	 26.35	 (CH2),	 25.92	 (CH2),	 25.89	 (CH2),	 24.05	
(CH2),	19.26	(CH2),	12.69	(CH3‐21),	12.50	(CH3‐18),	7.99	(CH3‐
Et),	7.60	(CH3‐Et).	 IR	(NaCl,	ν,	cm‐1):	3491,	3361,	2964,	2879,	
2347,	1713,	1460,	1381,	1245,	1145,	958,	890,	755.	MS	(ESI+)	
(m/z,	 (%)):	 359.25	 ((M+Na)+,	 47),	 319.26	 ((M‐OH)+,	 100).	
HRMS	 (ESI+):	 Calculated	 for	 C21H36NaO3,	 359.25567	 g/mol;	
Found:	359.25562	g/mol.	
	
3.	Results	and	discussion	
	
The	 compound	 1	 was	 prepared	 by	 a	 facile	 oxidation	 of	
compound	2	with	pyridinium	dichromate	in	dichloromethane	
(Scheme	 1).	 Suitable	 X‐ray	 crystals	 diffraction	 was	 obtained	
after	 recrystallization	 of	 compound	 1	 in	 a	 mixture	 of	
hexane:ethyl	 ether	 (1:1,	 v:v).	 The	 afforded	 compound	 is	
soluble	 in	 common	 organic	 solvent	 such	 as	 chloroform.	 The	
mass	 spectrum	 of	 the	 compound	 1	 present	 a	 peak	 at	
359.25562	 amu	 corresponding	 to	 the	 molecular	 ion	 of	
[1+Na]+.	 The	 infrared	 spectrum	 of	 the	 compound	 shows	
absorption	band	pointed	at	1713	cm‐1	which	is	assigned	to	the	
ν(C=O)	 vibration	 confirming	 the	 oxidation	 of	 the	 secondary	
alcohol	 function	 of	 compound	 2.	 	 In	 addition	 the	 13C	 NMR	
spectrum	 recorded	 in	 deuterated	 chloroform	 shows	 a	
characteristic	signal	at	δ	211.91	ppm	which	is	assigned	to	the	
C=O.	
The	molecular	structure	of	the	title	compound	is	shown	in	
Figure	 1.	 Crystallographic	 data,	 selected	 bond	 lengths	 and	
angles,	 hydrogen‐bond	 geometry	 and	 atomic	 displacement	
parameters	are	listed	respectively	in	Table	1‐4.	The	compound	
crystallizes	 in	 the	non‐centrosymmetric	 space	group	P21	 and	
the	 absolute	 structure	 was	 unambiguously	 established.	 The	
molecule	 contains	 a	 cyclopentane	 ring	 trans‐fused	 to	 a	
cyclohexanone	ring.	The	lateral	chain	contains	an	oxolane	ring.	
The	 cyclohexanone	 ring	 adopts	 a	 chair	 conformation.	 The	
cyclopentane	 ring	 is	 an	 envelope	 (Flap	 atom	 =	 C5)	 and	 the	
tetrahydrofuran	ring	 is	 twisted	about	C13‐O2.	The	configure‐
tions	 of	 the	 stereogenic	 centres	 are	 C5(R),	 C6(R),	 C9(R),	
C11(S),	C13(R)	and	C16(R).	There	is	an	intramolecular	O‐H···O	
hydrogen	bond	 involving	 the	hydroxyl	group	(O3‐H3)	and	an	
oxolane	O	atom	(O2),	generating	an	S(5)	ring	motif	 (Figure	1	
and	 Table	 4).	 The	 bond	 lengths	 and	 angles	 are	 normal	 and	
comparable	 to	 those	 observed	 in	 compounds	 containing	 the	
bicyclic	 moiety	 fragment	 (1S,3aR,7aR)‐1‐ethyl‐7a‐methyl‐
octahydroinden‐4‐one);	 specially	 in	 our	 recent	 work	 [10],	
which	 concerns	 an	 isomer	 of	 the	 title	 compound,	 adopting	 a	
very	similar	crystal	structure.	
In	the	crystal,	weak	C2‐H2B···O1=C	hydrogen	bonds	(Table	
4,	 Figure	 2)	 link	 the	 molecules	 into	 C(4)	 chains,	 which	
propagate	 parallel	 to	 [101].	 The	 chains	 are	 linked	 through	
extremely	 weak	 hydrogen	 bonds.	 Comparison	 of	 the	 crystal	
structure	 with	 that	 of	 the	 recent	 isomer	 we	 reported	 [10],	
shows	 that	 the	 two	 isomers	 adopt	 similar	 supramolecular	
architecture:	 hydrogen	 bonds	 linking	 molecules	 into	 chains,	
which	 propagate	 parallel	 to	 [101].	 In	 both	 structures,	 the	
chains	are	linked	by	very	weak	H	bonds.		
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Table	1.	Crystal	data	and	structure	refinement	for	compound	1.	
Empirical	formula		 C21H36O3		
Formula	weight		 336.50	
Temperature	(K)		 296(2)	
Crystal	shape	/	color	 Block/Colorless
Crystal	system		 Monoclinic	
Space	group		 P21
a	(Å)		 12.4156(19)	
b	(Å)	 6.3672(6)	
c	(Å)	 12.7186(12)		
α	(°)	 90		
β	(°)	 90.509(5)	
γ	(°)		 90		
Volume	(Å3)	 1005.4(2)		
Z		 2	
ρcalc		(g/cm3)	 1.112	
μ	(mm‐1)	 0.562	
F(000)		 372.0	
Crystal	size	(mm3)	 0.111	×	0.107	×	0.053	
Radiation		 CuKα	(λ	=	1.54178)	
2Θ	range	for	data	collection	(°)	 6.95	to	143.848	
Index	ranges		 ‐15	≤	h	≤	15,	‐7	≤	k	≤	7,	‐15	≤	l	≤	15		
Reflections	collected		 12352		
Independent	reflections		 3777	[Rint	=	0.0296,	Rsigma	=	0.0278]		
Data/restraints/parameters		 3777/1/221	
Goodness‐of‐fit	on	F2		 1.065	
Final	R	indexes	[I≥2σ	(I)]		 R1 =	0.0370,	wR2 =	0.1009	
Final	R	indexes	[all	data]		 R1 =	0.0384,	wR2 =	0.1039	
Largest	diff.	peak/hole	(e	Å‐3)	 0.18/‐0.13	
	
Table	2.	Bond	lengths	for	compound	1.	
Atom	 Atom	 Length	(Å) Atom Atom Length	(Å)
O1	 C1	 1.213(3)	 		 C7	 C8	 1.542(3)	
O2	 C16	 1.437(2)	 		 C8	 C9	 1.551(3)	
O2	 C13	 1.447(3)	 		 C9	 C11	 1.538(3)	
O3	 C17	 1.431(3)	 		 C11	 C12	 1.522(4)	
C1	 C6	 1.501(3)	 C11 C13 1.540(3)	
C1	 C2	 1.504(3)	 C13 C14 1.528(3)	
C2	 C3	 1.519(4)	 C14 C15 1.525(3)	
C3	 C4	 1.531(3)	 C15 C16 1.519(3)	
C4	 C5	 1.532(3)	 C16 C17 1.529(3)	
C5	 C10	 1.539(3)	 C17 C20 1.528(3)	
C5	 C9	 1.551(3)	 		 C17	 C18	 1.531(3)	
C5	 C6	 1.553(3)	 		 C18	 C19	 1.506(4)	
C6	 C7	 1.514(3)	 		 C20	 C21	 1.522(4)	
		
Table	3.	Bond	angles	for	compound	1.	
Atom	 Atom	 Atom	 Angle	(°) Atom Atom Atom Angle	(°)	
C16	 O2	 C13	 109.87(16) C5 C9 C8 103.55(16)
O1	 C1	 C6	 123.5(2)	 C12 C11 C9 114.17(19)
O1	 C1	 C2	 123.2(2)	 C12 C11 C13 111.22(18)
C6	 C1	 C2	 113.3(2)	 C9 C11 C13 109.33(17)
C1	 C2	 C3	 113.63(19) O2 C13 C14 105.57(17)
C2	 C3	 C4	 113.8(2)	 O2 C13 C11 110.18(18)
C3	 C4	 C5	 111.88(19)	 		 C14	 C13	 C11	 116.21(18)	
C4	 C5	 C10	 110.61(19)	 		 C15	 C14	 C13	 102.53(19)	
C4	 C5	 C9	 117.21(17) C16 C15 C14 101.03(18)
C10	 C5	 C9	 111.04(17)	 		 O2	 C16	 C15	 104.17(17)	
C4	 C5	 C6	 106.79(17) O2 C16 C17 107.87(16)
C10	 C5	 C6	 111.02(18) C15 C16 C17 118.20(19)
C9	 C5	 C6	 99.50(15) O3 C17 C20 106.00(18)
C1	 C6	 C7	 119.95(19) O3 C17 C16 109.04(17)
C1	 C6	 C5	 111.81(17) C20 C17 C16 109.75(19)
C7	 C6	 C5	 105.13(17) O3 C17 C18 108.45(18)
C6	 C7	 C8	 103.97(17)	 		 C20	 C17	 C18	 112.73(19)	
C7	 C8	 C9	 107.11(16) C16 C17 C18 110.69(18)
C11	 C9	 C5	 119.18(17)	 		 C19	 C18	 C17	 116.4(2)	
C11	 C9	 C8	 112.71(17)	 		 C21	 C20	 C17	 114.7(2)	
	
	
The	 title	 isomer	 is	 characterized	 by	 the	 presence	 of	 an	
intramolecular	hydrogen	bond	and	the	molecules	in	the	chains	
are	linked	by	weak	H	bonds.	On	the	contrary,	in	the	previously	
reported	 isomer,	 there	 is	 no	 intramolecular	 H	 bond	 and	 the	
molecules	 in	 the	 chains	 are	 strongly	 linked.	 It	 should	 be	
mentioned	that	 the	crystal	structure	change	between	the	two	
isomers	affected	mainly	the	unit	cell	lattice,	but	not	the	crystal	
system	 (monoclinic),	 nor	 the	 space	 group	 symmetry	 (P21).	
Indeed,	 the	 unit	 cell	 volume	 expands	 from	 the	 precedent	
isomer	to	the	title	isomer	(979.3	to	1005.3	Å3).	This	expansion	
resulted	from	contraction	in	the	c	parameter	and	the	increase	
of	 the	 a	 parameter,	 so	 that	 the	 c/a	 ratio	 and	 the	 β	 angle	
decreased	 from	1.8°	 to	1.0°	 and	104.2	 to	90.5	 °,	 respectively.	
The	b	parameter	remains	almost	unchanged.	
	
4.	Conclusion	
	
The	titled	compound	having	an	oxolane	moiety	in	his	side	
chain	was	synthesized	successfully	and	its	structure	has	been	
determined	by	X‐ray	single	crystallography.	One	of	his	stereo‐
isomer	was	previously	synthetized	and	reported	by	our	group.		
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Table	 4.	 Anisotropic	 displacement	 parameters	 (Å2×103)	 for	 compound	 1.	 The	 Anisotropic	 displacement	 factor	 exponent	 takes	 the	 form:	 																																					
‐2π2[h2a*2U11+2hka*b*U12+…].	
Atom	 U11	 U22	 U33 U23 U13 U12	
O1	 84.8(11)	 73.9(11)	 58.6(9) 5.9(8) 7.4(8) ‐0.2(9)	
O2	 79.6(10)	 49.9(8)	 55.5(8) 10.5(7) 15.0(7) 10.9(7)	
O3	 54.1(8)	 99.9(14)	 69.2(9) ‐1.4(10) ‐7.4(7) ‐4.6(9)	
C1	 64.2(12)	 50.8(12)	 60.3(12)	 ‐0.1(10)	 10.6(10)	 2.5(9)	
C2	 55.6(12)	 72.6(15)	 80.1(15)	 2.6(13)	 14.0(11)	 ‐3.9(11)	
C3	 51.9(12)	 77.9(16)	 90.0(17) ‐3.0(14) 3.0(11) ‐13.8(12)
C4	 53.3(11)	 69.7(14)	 65.3(12)	 ‐1.8(11)	 ‐4.6(9)	 ‐7.1(11)	
C5	 47.8(10)	 46.6(10)	 53.4(10)	 1.5(9)	 0.0(8)	 ‐1.7(9)	
C6	 51.2(10)	 51.5(11)	 55.2(11) ‐0.5(9) 2.6(8) ‐1.2(9)	
C7	 55.7(12)	 91.1(18)	 54.4(11) ‐8.7(12) 0.9(9) ‐8.4(12)	
C8	 49.1(10)	 72.7(14)	 58.0(11) ‐1.3(11) 1.9(8) ‐6.4(10)	
C9	 49.4(10)	 43.7(10)	 51.7(10) 1.9(8) 0.3(8) ‐1.2(8)	
C10	 75.8(15)	 50.5(12)	 72.4(14) 6.3(10) 10.3(12) 2.8(11)	
C11	 61.9(12)	 45.8(10)	 54.2(10)	 1.6(9)	 6.5(9)	 ‐1.7(9)	
C12	 87.3(17)	 81.1(18)	 61.6(13) ‐13.9(13) 5.7(12) ‐24.3(14)
C13	 58.9(11)	 53.9(12)	 52.3(10)	 2.6(10)	 5.4(9)	 1.4(9)	
C14	 68.5(13)	 47.4(11)	 65.8(13)	 ‐4.0(9)	 6.2(11)	 ‐2.6(10)	
C15	 74.0(14)	 47.5(11)	 62.8(12)	 4.5(10)	 4.6(10)	 ‐6.5(10)	
C16	 55(1)	 45.3(10)	 55.5(10) 7.5(8) ‐1.9(8) ‐1.2(8)	
C17	 50.7(10)	 52.7(11)	 53.2(10) 5.7(9) ‐2.6(8) ‐4.3(9)	
C18	 63.8(12)	 52.2(11)	 63.2(12) 6.4(10) 8(1) 2.4(10)	
C19	 81.3(17)	 70.5(16)	 92.6(19) ‐22.7(15) ‐2.2(14) ‐9.7(14)	
C20	 82.4(16)	 56.4(13)	 64.6(13) 10.5(11) 5.7(12) ‐12.0(12)
C21	 116(2)	 91(2)	 71.2(16) 7.6(16) 25.6(16) ‐26.4(19)
	
Table	5.	Hydrogen	bonds	for	compound	1.	
D	 H	 A	 d(D‐H)	(Å) d(H‐A)	(Å) d(D‐A)	(Å)	 D‐H‐A	(°)
O3	 H3	 O2	 0.82	 2.34	 2.766(2)	 112.6	
C2	 H2B	 O11	 0.97	 2.55	 3.267(4)	 130.7	
1	1‐x,	‐1/2+y,	‐z.	
	
	
	
Figure	2. Three	dimensional	network	of	compound	1.
	
In	 future,	 the	 biological	 activities	 of	 these	 two	 calcitriol	
analogues	will	be	studied.	
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